Why is Ambey Laborator. falling/rising?

As of 05-Sep, Ambey Laboratories Ltd is currently priced at 42.40, reflecting a slight increase of 0.05 or 0.12%. The stock has shown a positive performance today, outperforming its sector by 1.15%. Over the past week, it has risen by 4.95%, while its one-month return is a modest 0.95%. However, the stock has experienced significant declines year-to-date and over the past year, with losses of 33.49% and 43.84%, respectively. Despite being higher than the 5-day, 20-day, 50-day, and 100-day moving averages, it remains below the 200-day moving average. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 47.37% against the 5-day average, indicating a potential concern regarding trading interest.
In the broader market context, Ambey Laboratories Ltd has outperformed the Sensex benchmark in the short term, with a 1-week return of 4.95% compared to the Sensex's 1.29%. However, the stock's long-term performance is concerning, as it has underperformed significantly over the year and year-to-date compared to the benchmark's positive returns. The liquidity of the stock is adequate for trading, as it is based on 2% of the 5-day average traded value. Overall, while there are some positive short-term movements, the long-term trends and declining investor participation suggest caution among investors.